City

Baltimore (1)

Beijing (1)

Boston (1)

Condition

Mesenchymal Tumor (3)

Autoimmune Pancreatitis (1)

Lymphoma (1)

Oncogenic Osteomalacia (1)

Solid Tumors (1)

Overall Status

Completed (1)

Unknown status (1)

Withdrawn (1)

Sign in for free

Phase

early phase 1 (1)

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Johns Hopkins University (1)

Massachusetts General Hospital (1)

Peking Union Medical College Hospital (1)

Collaborator

Intervention

68ga-dotatate (1)

eus-fnb with procore needle (1)

eus-fnb with sharkcore needle (1)

interoperative radiation (1)

photon beam radiation (1)

procore needle (1)

proton beam radiation (1)

sharkcore needle (1)

Study Documents

Intervention Type

device (1)

drug (1)

procedure (1)

radiation (1)

Funder Type

Other (3)

Study Type

Interventional (3)

mesenchymal tumor

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Mesenchymal Tumor, Autoimmune Pancreatitis, Lymphoma Trial in Baltimore (EUS-FNB with ProCore needle, EUS-FNB with SharkCore

Withdrawn

Mesenchymal Tumor
+3 more

EUS-FNB with ProCore needle
+3 more

Baltimore, Maryland

Johns Hopkins Hospital

May 11, 2017

Oncogenic Osteomalacia, Mesenchymal Tumor Trial in Beijing (68Ga-DOTATATE)

Unknown status

Oncogenic Osteomalacia
Mesenchymal Tumor

68Ga-DOTATATE

Beijing, China

Department of Nuclear Medicine, Peking Union Medical College Hop

Apr 5, 2017

Mesenchymal Tumor Trial in Boston (Proton Beam Radiation, Photon Beam Radiation, Interoperative radiation)

Completed

Mesenchymal Tumor

Proton Beam Radiation
+2 more

Boston, Massachusetts

Massachusetts General Hospital

Feb 2, 2017